Results 51 to 60 of about 376 (122)

Dupilumab as a Therapeutic Option in Autoimmune Bullous Diseases Following SARS‐CoV‐2 Infection and COVID‐19 Vaccination: A Comprehensive Case Series Analysis

open access: yesDermatologic Therapy, Volume 2025, Issue 1, 2025.
The global vaccination campaign against SARS‐CoV‐2, started in December 2021, is the primary defense against COVID‐19. Since then, the scientific community has been actively investigating the potential increase in autoimmune and autoinflammatory conditions linked to both the infection and vaccination, particularly with recombinant‐mRNA Comirnaty ...
Francesca Svara   +11 more
wiley   +1 more source

Drug‐ and Vaccine‐Induced Cutaneous T‐Cell Lymphoma: A Systematic Review of the Literature

open access: yesJournal of Skin Cancer, Volume 2025, Issue 1, 2025.
Cutaneous T‐cell lymphomas (CTCLs) are a type of non‐Hodgkin lymphoma that usually involves the skin. It has different subtypes including mycosis fungoides (MFs), Sézary syndrome (SS), primary cutaneous anaplastic large lymphoma (PC‐ALCL), lymphomatoid papulosis (LyP), and subcutaneous panniculitis–like T‐cell lymphoma (SPTCL).
Ifa Etesami   +13 more
wiley   +1 more source

Benign and malignant cutaneous nasal lesions

open access: yesEye &ENT Research, Volume 1, Issue 2, Page 65-91, December 2024.
Abstract The nose is a structure of both cosmetic and functional importance. Cutaneous lesions of the nose occasionally represent a diagnostic challenge and involve the expertise of several specialties from dermatology, otolaryngology—head and neck surgery, infectious disease, and pathology, among others.
Hamed Sarikhani   +4 more
wiley   +1 more source

Therapeutic Plasma Exchange for the Symptomatic Treatment of Scleromyxedema: A Case Report and Literature Review

open access: yesJournal of Clinical Apheresis, Volume 39, Issue 6, December 2024.
ABSTRACT Scleromyxedema is a rare skin mucinosis often associated with systemic involvement and monoclonal gammopathy (MG). No formal recommendation for management with therapeutic plasma exchange (TPE) has been published due to rarity. This paper reports a 42‐year‐old male with progressive scleromyxedema.
Matthew H. Lanehart   +2 more
wiley   +1 more source

Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxoedema and scleroedema

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 38, Issue 7, Page 1281-1299, July 2024.
Abstract The term ‘sclerosing diseases of the skin’ comprises specific dermatological entities, which have fibrotic changes of the skin in common. These diseases mostly manifest in different clinical subtypes according to cutaneous and extracutaneous involvement and can sometimes be difficult to distinguish from each other.
Robert Knobler   +29 more
wiley   +1 more source

Prevalence of Histopathologic Types of Gingival Lesions in the Iranian Population: A 22‐Year Retrospective Study

open access: yesClinical and Experimental Dental Research, Volume 10, Issue 3, June 2024.
ABSTRACT Objectives Gingiva is one of the supporting tissues around the teeth that can be affected by various neoplastic or nonneoplastic lesions. Previous studies have examined several types of gingival lesions, but the lack of a standardized classification system has hindered meaningful comparisons.
Nafiseh Shamloo   +2 more
wiley   +1 more source

Oral focal mucinosis of gingiva - a rare case report and review of literature

open access: yes, 2017
Oral focal mucinosis (OFM) is a rare soft-tissue lesion of unknown etiology. Clinically it appears as asymptomatic round lesions and histologically, characterized by focal myxoid degeneration of connective tissue with presence of stellate shaped ...
Govind Rajkumar   +3 more
core   +1 more source

Wound, pressure ulcer, and burn guidelines (2023)―4: Guidelines for the management of connective tissue disease/vasculitis‐associated skin ulcers, third edition

open access: yes
The Journal of Dermatology, Volume 52, Issue 6, Page e430-e480, June 2025.
Yoshihide Asano   +27 more
wiley   +1 more source

Focal oral mucinosis : a systematic review

open access: yes, 2023
A mucinose oral focal (MOF) é uma lesão benigna, que acomete a cavidade bucal, mas sua exata etiologia permanece desconhecida. A MOF é uma lesão rara, sendo descrita na literatura pela primeira vez em 1974 pelo Dr.
Fucks, Larissa Dill
core  

Oral focal mucinosis: clinical case presentation with a focus on aesthetic and functional surgical resolution

open access: yes, 2014
Introduction: When planning excisional surgery, alterations in the oral mucosa, particularly in esthetically important areas, represent a challenge. For cases involving an exophytic lesion with a vegetative tumoral aspect, a clinician may prioritize ...
Macarini, Valmir Campos   +24 more
core   +1 more source

Home - About - Disclaimer - Privacy